1. Home
  2. OVLY vs TVRD Comparison

OVLY vs TVRD Comparison

Compare OVLY & TVRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oak Valley Bancorp (CA)

OVLY

Oak Valley Bancorp (CA)

N/A

Current Price

$27.75

Market Cap

219.0M

Sector

Finance

ML Signal

N/A

TVRD

Tvardi Therapeutics Inc. Common Stock

HOLD

Current Price

$4.30

Market Cap

246.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OVLY
TVRD
Founded
1990
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
219.0M
246.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OVLY
TVRD
Price
$27.75
$4.30
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$51.67
AVG Volume (30 Days)
8.4K
125.4K
Earning Date
01-23-2026
11-13-2025
Dividend Yield
2.13%
N/A
EPS Growth
N/A
N/A
EPS
2.84
N/A
Revenue
$79,783,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.74
N/A
Revenue Growth
2.98
N/A
52 Week Low
$22.70
$3.74
52 Week High
$32.24
$43.65

Technical Indicators

Market Signals
Indicator
OVLY
TVRD
Relative Strength Index (RSI) 52.73 31.07
Support Level $27.66 $4.05
Resistance Level $28.25 $4.40
Average True Range (ATR) 0.45 0.27
MACD -0.04 0.63
Stochastic Oscillator 68.28 83.33

Price Performance

Historical Comparison
OVLY
TVRD

About OVLY Oak Valley Bancorp (CA)

Oak Valley Bancorp is a bank holding company that operates through Oak Valley Community Bank (the Bank). The Bank offers a complement of business checking and savings accounts for its business customers. The Bank also offers commercial and real estate loans, as well as lines of credit. In addition, the bank provides other services for both individuals and businesses including online banking, remote deposit capture, mobile banking, merchant services, night depository, extended hours, wire transfer of funds, note collection, and automated teller machines in a national network. Its primary source of revenue is net interest income.

About TVRD Tvardi Therapeutics Inc. Common Stock

Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.

Share on Social Networks: